Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy

NCT04640818 · clinicaltrials.gov ↗

UNKNOWN

Status

45

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Cladribine Oral Tablet
DRUG: Rituximab
DRUG: Ocrelizumab

Sponsor

Claudio Gobbi

Collaborators

[object Object]